Citations for
1CDKN2A, CDKN2B, MNST
Comprehensive analysis of CDKN2A (p16INK4A/p14ARF) and CDKN2B genes in 53 melanoma index cases considered to be at heightened risk of melanoma.
Laud K, Marian C, Avril MF, Barrois M, Chompret A, Goldstein AM, Tucker MA, Clark PA, Peters G, Chaudru V, Demenais F, Spatz A, Smith MW, Lenoir GM, Bressac-de Paillerets B; French Hereditary Melanoma Study Group.
J Med Genet 43(1):39-47. Epub 2005 Jun 3. 2006
2CDKN2A, MNST
A novel type of deletion in the CDKN2A gene identified in a melanoma-prone family.
Knappskog S, Geisler J, Arnesen T, Lillehaug JR, Lonning PE.
Genes Chromosomes Cancer 45(12):1155-63. 2006
3CDKN2A, CDKN2B, MNST
A germline deletion of p14(ARF) but not CDKN2A in a melanoma-neural system tumour syndrome family.
Randerson-Moor JA, Harland M, Williams S, Cuthbert-Heavens D, Sheridan E, Aveyard J, Sibley K, Whitaker L, Knowles M, Newton Bishop J , Bishop DT.
Hum Mol Genet 10(1):55-62. 2001
4CDKN2A, CDKN2B, MNST
Germ-line deletion involving the INK4 locus in familial proneness to melanoma and nervous system tumors.
Bahuau M, Vidaud D, Jenkins RB, Bieche I, Kimmel DW, Assouline B, Smith JS, Alderete B, Cayuela JM, Harpey JP, Caille B, Vidaud M.
Cancer Res 58(11):2298-303. 1998